Arecor subsidiary Tetris launching Ogluo in the Netherlands
29th Feb 2024 14:12
(Sharecast News) - Arecor Therapeutics updated the market on an announcement made by its subsidiary Tetris Pharma on Thursday, regarding the launch of the 'Ogluo' glucagon prefilled autoinjector pen in the Netherlands.
Read moreArecor appoints new commercial manager to Tetris subsidiary
3rd Jan 2024 13:44
(Sharecast News) - Arecor Therapeutics announced the appointment of Dr Helen Parris as senior vice president and commercial and general manager of its subsidiary Tetris Pharma on Wednesday.
Read moreArecor inks co-development deal with global medicine company
4th Dec 2023 09:49
(Sharecast News) - Arecor Therapeutics announced a co-development and exclusive licence option agreement with an unnamed global medical products company on Monday.
Read moreArecor gets milestone payment from Arestat partner
17th Nov 2023 12:06
(Sharecast News) - Arecor Therapeutics announced a significant milestone in its collaboration with a global pharmaceutical partner on Friday.
Read moreArecor inks partnership with unnamed pharma giant
17th Aug 2023 15:55
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics has entered into a partnership agreement with an unnamed global top-10 pharmaceutical company, it announced on Thursday.
Read moreArecor Therapeutics appoints new chief business officer
5th Apr 2023 14:07
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics announced the appointment of Dr Manjit Rahelu as its chief business officer on Wednesday.
Read moreArecor Therapeutics begins type-2 diabetes trial
22nd Mar 2023 17:01
(Sharecast News) - Arecor Therapeutics announced the start of the phase one clinical trial for its ultra-rapid acting insulin candidate 'AT278' on Wednesday, with the first patient being dosed.
Read moreArecor granted three patents in US, India
16th Feb 2023 18:11
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics has received patents for its novel formulations of insulin and adalimumab, it announced on Thursday.
Read moreArecor ends 2022 in line with forecasts
19th Jan 2023 16:05
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics said in an update on Thursday that its financial performance for 2022 was in line with market expectations, as it closed the period with an unaudited cash balance of £12.8m.
Read moreArecor's Tetris launches 'Ogluo' in Austria
4th Jan 2023 16:01
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics announced on Wednesday that its subsidiary Tetris Pharma has launched 'Ogluo', or glucagon prefilled autoinjector pens, as a treatment for severe hypoglycaemia in children and adults living with diabetes in Austria.
Read moreArecor inks formulation study deal with 'leading' pharma firm
10th Nov 2022 14:01
(Sharecast News) - Biopharmaceuticals developer Arecor Therapeutics has signed an exclusive formulation study collaboration with the pharmaceutical division of "one of the world's largest" chemicals marketing and pharma companies, it announced on Thursday, which focuses on the development and commercialisation of speciality drugs.
Read moreArecor's Tetris launches hypoglycaemia treatment in Germany
1st Nov 2022 16:41
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics announced on Tuesday that its subsidiary Tetris Pharma has launched the 'Ogluo' glucagon-prefilled autoinjector pen as a treatment for severe hypoglycaemia in children and adults living with diabetes in Germany.
Read moreArecor gets two EU patents for adalimumab formulations
9th Aug 2022 13:54
(Sharecast News) - Biopharmaceutical developer Arecor Therapeutics has been granted two European patents protecting its novel formulations of high-concentration 'adalimumab' until 2038, it announced on Tuesday.
Read moreExpectations exceeded for Arecor's two lead clinical-stage programmes
23rd May 2022 12:21
(Sharecast News) - Biopharmaceutical developer Arecor Therapeutics said in an update on Monday that it was making "huge strides" on its growth trajectory, focussed on its two lead clinical-stage programmes.
Read moreArecor granted first US patent for insulin formulations
23rd Mar 2022 13:47
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics announced on Wednesday that the United States Patent and Trademark Office has granted a patent protecting novel formulations of its proprietary insulin products, 'AT247' and 'AT278'.
Read more